First Horizon Advisors, Inc. - Astellas Pharma Inc ownership

Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 5 filers reported holding Astellas Pharma Inc in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
First Horizon Advisors, Inc. ownership history of Astellas Pharma Inc
ValueSharesWeighting
Q3 2023$1,578
-6.8%
1140.0%0.00%
Q2 2023$1,694
+5.1%
1140.0%0.00%
Q1 2023$1,612
-6.9%
1140.0%0.00%
Q4 2022$1,732114
+208.1%
0.00%
Q3 2022$0370.0%0.00%
Q2 2022$0
-100.0%
37
-69.2%
0.00%
Q4 2021$1,000
-66.7%
120
-41.2%
0.00%
Q3 2021$3,000
-25.0%
204
-14.6%
0.00%
Q2 2021$4,000
+33.3%
2390.0%0.00%
Q1 2021$3,000
-40.0%
239
-29.1%
0.00%
Q4 2020$5,0000.0%3370.0%0.00%
Q3 2020$5,0000.0%3370.0%0.00%
Q2 2020$5,0000.0%337
-5.6%
0.00%
Q1 2020$5,000
-16.7%
3570.0%0.00%
Q4 2019$6,000
+20.0%
3570.0%0.00%
Q3 2019$5,0000.0%3570.0%0.00%
Q2 2019$5,0000.0%3570.0%0.00%
Q1 2019$5,000
+25.0%
3570.0%0.00%
Q4 2018$4,000
-33.3%
357
-7.0%
0.00%
Q3 2018$6,000
+20.0%
3840.0%0.00%
Q2 2018$5,0000.0%3840.0%0.00%
Q1 2018$5,0000.0%3840.0%0.00%
Q4 2017$5,0000.0%384
-3.5%
0.00%
-100.0%
Q3 2017$5,0000.0%3980.0%0.00%0.0%
Q2 2017$5,000
+25.0%
398
+9.6%
0.00%
Q1 2017$4,000
+100.0%
363
+70.4%
0.00%
Q4 2016$2,0000.0%2130.0%0.00%
Q3 2016$2,0002130.00%
Q2 2015$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q1 2015$8,000
+14.3%
5080.0%0.00%0.0%
Q4 2014$7,0000.0%5080.0%0.00%0.0%
Q3 2014$7,0000.0%5080.0%0.00%0.0%
Q2 2014$7,000
+75.0%
508
+40.3%
0.00%0.0%
Q1 2014$4,0000.0%362
+24.8%
0.00%0.0%
Q4 2013$4,000
+100.0%
290
+102.8%
0.00%
Q3 2013$2,0001430.00%
Other shareholders
Astellas Pharma Inc shareholders Q3 2022
NameSharesValueWeighting ↓
RENAISSANCE GROUP LLC 391,745$5,438,8800.25%
Cassady Schiller Wealth Management, LLC 698$9,6670.01%
MAI Capital Management 19,087$264,3620.00%
SVB WEALTH LLC 10,472$145,0370.00%
RHUMBLINE ADVISERS 34,759$481,4080.00%
First Horizon Advisors, Inc. 114$1,5780.00%
Operose Advisors LLC 90$1,2470.00%
Russell Investments Group, Ltd. 783$10,8450.00%
PNC FINANCIAL SERVICES GROUP, INC. 166$2,2990.00%
View complete list of Astellas Pharma Inc shareholders